Upgrade to SI Premium - Free Trial

Decoy Therapeutics (DCOY)

4.95 +0.03 (0.61%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Form EFFECT Decoy Therapeutics Inc. July 20, 2026 6:02 AM - SEC Filing Form 424B3 Decoy Therapeutics Inc. July 17, 2026 5:08 PM - SEC Filing Form 8-K Decoy Therapeutics Inc. For: Jul 14 July 15, 2026 5:14 PM - SEC Filing Decoy Therapeutics elects Moderna executive to its board July 15, 2026 9:25 AM - StreetInsider Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors July 15, 2026 9:25 AM - PR NewsWire Decoy Therapeutics (DCOY) files for 3.77M share offering by selling stockholders July 10, 2026 4:28 PM - StreetInsider Form S-1 Decoy Therapeutics Inc. July 10, 2026 4:26 PM - SEC Filing 4 Sizzling Biotech and Healthcare Companies Reporting Strategic Milestones June 29, 2026 9:51 AM - StreetInsider Form 8-K Decoy Therapeutics Inc. For: Jun 26 June 29, 2026 6:04 AM - SEC Filing Decoy Therapeutics announces up to $21M private placement June 26, 2026 8:12 PM - StreetInsider Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing June 26, 2026 8:12 PM - PR NewsWire Form EFFECT Decoy Therapeutics Inc. June 25, 2026 6:03 AM - SEC Filing Decoy Therapeutics (DCOY) files for 808K share offering by selling stockholders June 15, 2026 6:13 AM - StreetInsider Form S-1 Decoy Therapeutics Inc. June 15, 2026 6:11 AM - SEC Filing Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London June 8, 2026 8:00 AM - PR NewsWire Form RW Decoy Therapeutics Inc. June 5, 2026 4:33 PM - SEC Filing Form DEFA14A Decoy Therapeutics Inc. June 4, 2026 8:30 AM - SEC Filing Form DEF 14A Decoy Therapeutics Inc. For: Jun 04 June 4, 2026 8:27 AM - SEC Filing Decoy Therapeutics nominates Patricia Gauthier for board election June 3, 2026 8:01 AM - StreetInsider Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors June 3, 2026 8:00 AM - PR NewsWire Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic June 1, 2026 7:00 AM - PR NewsWire Decoy Therapeutics names MIT professor as advisory board chair May 26, 2026 8:15 AM - StreetInsider Decoy Therapeutics Names Brad Pentelute, MIT Professor of Chemistry, as Chair of Scientific Advisory Board May 26, 2026 8:15 AM - PR NewsWire Form 8-K Decoy Therapeutics Inc. For: May 19 May 19, 2026 4:07 PM - SEC Filing Form 10-Q Decoy Therapeutics Inc. For: Mar 31 May 8, 2026 4:46 PM - SEC Filing Form 10-K/A Decoy Therapeutics Inc. For: Dec 31 April 30, 2026 1:03 PM - SEC Filing Decoy Therapeutics to Present at Two Peptide Therapeutics Conferences in Boston April 27, 2026 8:45 AM - PR NewsWire Full Article List